ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q2Scopus Q2SCImago #5,063Hybrid

Neuromolecular Medicine

Acronym:nemm
•
Abbreviation (ISO):NEUROMOL MED
•
Identifier (ISSN):1535-1084(Print)/1559-1174(Online)
•
Publisher:Springer US
Clarivate IF (2026)
3.8↓ -0.1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q2
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Neuromolecular Medicine

WoS Q2
13462.9520182.5820192.6320203.8420214.120223.520233.320243.920253.82026
Annual Impact Factor Metric
Current (2026):3.8
Scopus SJR & RankScopus Q2
0.979
#5,063

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
89

89 papers with at least that number of citations each

WoS: SCIE / JCRQ2
Self-Citation Rate0%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
58articles/year
27.16% Gold OA•73.53% Original Research

Aims & Scope

NeuroMolecular Medicine publishes cutting-edge original research articles and critical reviews on the molecular and biochemical basis of neurological disorders. Studies range from genetic analyses of human populations to animal and cell culture models of neurological disorders. Emerging findings concerning the identification of genetic aberrancies and their pathogenic mechanisms at the molecular and cellular levels will be included. Also covered are experimental analyses of molecular cascades involved in the development and adult plasticity of the nervous system, in neurological dysfunction, and in neuronal degeneration and repair. NeuroMolecular Medicine encompasses basic research in the fields of molecular genetics, signal transduction, plasticity, and cell death. The information published in NEMM will provide a window into the future of molecular medicine for the nervous system.

Topics Covered (Recognized by AI)
Biology97.8%Medicine94.7%Chemistry87.3%Internal medicine85.9%Genetics85.5%Biochemistry85.1%Psychology75%Neuroscience67.9%Pathology54%Gene53.5%Psychiatry50.5%Endocrinology49.2%Cell biology39.3%Disease39.1%Immunology27.6%Receptor27.1%Physics26.5%Organic chemistry24.1%Neurology23%Pharmacology21%
Primary Research Areas

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

NEUROSCIENCES

Q2
Rank118/330
IndexSCIE
JCISCIE2026

NEUROSCIENCES

Q2
Rank139/330
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF3.8
Articles / Year50
Total Citations28
2025
IF3.9
Articles / Year76
Total Citations329
2024
IF3.3
Articles / Year54
Total Citations343
2023
IF3.5
Articles / Year34
Total Citations422
2022
IF4.103
Articles / Year35
Total Citations622

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #5,063Scopus Q2SCImago Profile
Scopus Coverage:2002-2026
Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyNeuroscience
Scopus Citation Rank (SJR)Q2
0.979

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2
Citations / Doc (2 years)
3.63

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,337 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations565
3-Year Documents152
Citable Documents151

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.1%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Molecular MedicineQ2
NeurologyQ2
Cellular and Molecular NeuroscienceQ3
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
3区 (Zone 3)Medicine
Minor Category (Specific Field):
3区NEUROSCIENCES
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Neuromolecular Medicine (acronym: nemm, abbr: NEUROMOL MED, ISSN: 1535-1084) is a peer-reviewed international scholarly journal in the field of Medicine, published by Springer US in United States since 2002. The periodical holds a Journal Impact Factor (JIF) of 3.80, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.979 (Q2), an H-index of 89.

The journal enforces rigorous peer evaluation with a publication frequency of Quarterly, an annual output of approximately 58 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,337 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Springer US
Publication Language
English
Frequency
Quarterly
Founding Year
2002
Indexing & Databases
SCIEScopusPubMed
Editorial Address
HUMANA PRESS INC, 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, USA, NJ, 07512

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: 91d6af6b-3a88-4358-984c-199942029077
Database Updated: 2026-09-29